Skip to content

Prospective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure Treated With Bilevel Positive Airway Pressure as Second-line Therapy.

Prospective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure, Treated With Bilevel Positive Airway Pressure (AirCurve 10 VAutoTM) as Second-line Therapy: PoP IN VAuto

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02930460
Acronym
PoP IN VAuto
Enrollment
30
Registered
2016-10-12
Start date
2016-11-30
Completion date
2019-02-28
Last updated
2020-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

Prospective observational study of obstructive Sleep Apnea patients treated with Bilevel Positive Airway Pressure: AirCurve 10 VAutoTM

Detailed description

To characterize, in routine practice, non compliant patient to continuous positive airway pressure who can get a benefit of a bilevel positive airway pressure therapy as a second line treatment (Aircurve 10 VAutoTM ) To evaluate the clinical management of obstructive sleep apnea patients treated by Aircurve 10 VAutoTM , especially impact on compliance and residual apnea hypopnea Index. To evaluate Aircurve 10 VAutoTM benefit on quality of Life and quality of sleep

Interventions

None listed

Sponsors

ResMed
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient * Obstructive Sleep Apnea Patient previously treated by Continuous positive airway pressure non-compliant to therapy * Patient naive of bilevel Positive Airway Pressure therapy

Exclusion criteria

* Bilevel positive airway pressure Contraindication * Severe respiratory disease diagnostic

Design outcomes

Primary

MeasureTime frameDescription
Compliance3 monthshours of usage of the device per night

Secondary

MeasureTime frameDescription
sleepiness3 monthsEpworth sleepiness score evolution
sleep quality3 monthsPittsburgh sleep questionnaire index

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026